SCHEMBL29935910

SCHEMBL29935910

COc1ccc(C=O)c(C)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 1/20 0.50
PDE10A Q9Y233 10/20 0.45
ERN1 O75460 4/20 0.43
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 1/20 0.41
TRIM24 O15164 1/20 0.40
TYR P14679 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PDE2A O00408 2/20 0.39
PDE5A O76074 2/20 0.39
PDE7A Q13946 2/20 0.39
PDE11A Q9HCR9 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3A Q14432 1/20 0.39
PDE7B Q9NP56 1/20 0.39
BRD9 Q9H8M2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14032801 1.00 NNMT (0.50) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL4598347 0.82 ALDH1A1 (0.50) ERN1CYP1A2KMT2AALDH1A1TRIM24
SCHEMBL23046187 0.82 ERN1 (0.42) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL29952654 0.82 ERN1 (0.52) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL1534756 0.82 ERN1 (0.52) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL28153665 0.82 ERN1 (0.46) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL6792316 0.80 ERN1 (0.42) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL10322362 0.80 ERN1 (0.41) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL21327305 0.80 ERN1 (0.41) NNMTPDE10AERN1CYP1A2KMT2A
SCHEMBL15228338 0.80 ALDH1A1 (0.45) NNMTPDE10AERN1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NNMT 4068/4885PDE10A 594/4885ERN1 3219/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH NNMT 4025/4885PDE10A 1367/4885ERN1 3111/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NNMT 4068/4885PDE10A 594/4885ERN1 3219/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP NNMT 4068/4885PDE10A 594/4885ERN1 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.